132 related articles for article (PubMed ID: 27404513)
1. Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.
Grabb MC; Cross AJ; Potter WZ; McCracken JT
J Clin Psychopharmacol; 2016 Oct; 36(5):419-21. PubMed ID: 27404513
[TBL] [Abstract][Full Text] [Related]
2. NIMH during the tenure of Director Herbert Pardes, M.D. (1978-1984): The President's Commission on Mental Health and the reemergence of NIMH's scientific mission.
Pardes H
Am J Psychiatry; 1998 Sep; 155(9 Suppl):14-9. PubMed ID: 9736859
[TBL] [Abstract][Full Text] [Related]
3. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
[No Abstract] [Full Text] [Related]
4. Historical highlights of the National Institute of Mental Health from 1946 to the present.
Judd LL
Am J Psychiatry; 1998 Sep; 155(9 Suppl):3-8. PubMed ID: 9736857
[TBL] [Abstract][Full Text] [Related]
5. NIMH's Straight and Neural Path: The Road to Killing Clinical Psychiatric Research.
Markowitz JC; Friedman RA
Psychiatr Serv; 2020 Nov; 71(11):1096-1097. PubMed ID: 32966168
[No Abstract] [Full Text] [Related]
6. Integrating NIMH's Research Domain Criteria (RDoC) Initiative into Psychiatry Resident Training.
Cozza EM; Shankman SA
Acad Psychiatry; 2022 Aug; 46(4):522-527. PubMed ID: 34642858
[No Abstract] [Full Text] [Related]
7. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development.
Krystal AD; Pizzagalli DA; Mathew SJ; Sanacora G; Keefe R; Song A; Calabrese J; Goddard A; Goodman W; Lisanby SH; Smoski M; Weiner R; Iosifescu D; Nurnberger J; Szabo S; Murrough J; Shekhar A; Potter W
Nat Rev Drug Discov; 2018 Dec; 18(1):82-84. PubMed ID: 30591715
[No Abstract] [Full Text] [Related]
8. National Institute of Mental Health: Psychotherapeutic Medications Development Program.
Haigler HJ; Koslow SH
J Clin Psychopharmacol; 1992 Aug; 12(4):231-3. PubMed ID: 1527224
[No Abstract] [Full Text] [Related]
9. Joint FDA, NCI program aims to streamline cancer drug development.
FDA Consum; 2003; 37(4):11. PubMed ID: 12971341
[No Abstract] [Full Text] [Related]
10. An active National Institute of Mental Health.
Varmus H
Science; 1995 Jun; 268(5218):1681. PubMed ID: 7792582
[No Abstract] [Full Text] [Related]
11. Medicine. What are the right targets for psychopharmacology?
Hyman SE; Fenton WS
Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
[No Abstract] [Full Text] [Related]
12. The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993.
Haigler HJ
Psychopharmacol Bull; 1994; 30(1):19-22. PubMed ID: 7972624
[No Abstract] [Full Text] [Related]
13. NIMH Drug Trials for Schizophrenia.
Torrey EF; Yolken RH; Lamb HR
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677268
[No Abstract] [Full Text] [Related]
14. Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program.
Das S; Lo AW
Contemp Clin Trials; 2017 Nov; 62():168-174. PubMed ID: 28899813
[TBL] [Abstract][Full Text] [Related]
15. Anxiety hits mental health institute.
Marshall E
Science; 1994 May; 264(5160):764-6. PubMed ID: 8171328
[No Abstract] [Full Text] [Related]
16. [Multicenter psychopharmacologic research and the data bank].
Cassano GB; Conti L; Massimetti G
Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
[TBL] [Abstract][Full Text] [Related]
17. From Neurobiology to Novel Medications: A Principled Approach to Translation.
Gordon JA
Am J Psychiatry; 2019 Jun; 176(6):425-427. PubMed ID: 31154816
[No Abstract] [Full Text] [Related]
18. [NIMH--grant and research system].
Takayama U
Seishin Shinkeigaku Zasshi; 1991; 93(6):446-56. PubMed ID: 1891504
[No Abstract] [Full Text] [Related]
19. NIMH-funded pragmatic trials: moving on.
Wang PS; Insel TR
Neuropsychopharmacology; 2010 Dec; 35(13):2489-90. PubMed ID: 21068745
[No Abstract] [Full Text] [Related]
20. The Continuing Decline of Clinical Research on Serious Mental Illnesses at NIMH.
Torrey EF; Simmons WW; Hancq ES; Snook J
Psychiatr Serv; 2021 Nov; 72(11):1342-1344. PubMed ID: 33820442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
